Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure

OBJECTIVE: Although vasodilators are used in acute heart failure (AHF) management, there have been no clear supportive evidence regarding their routine use. Recent European guidelines recommend systolic blood pressure (SBP) reduction in the range of 25% during the first few hours after diagnosis. Th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Heart
Asıl Yazarlar: Kitai, Takeshi, Tang, W H Wilson, Xanthopoulos, Andrew, Murai, Ryosuke, Yamane, Takafumi, Kim, Kitae, Oishi, Shogo, Akiyama, Eiichi, Suzuki, Satoshi, Yamamoto, Masayoshi, Kida, Keisuke, Okumura, Takahiro, Kaji, Shuichiro, Furukawa, Yutaka, Matsue, Yuya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2018
Konular:
Heart Failure and Cardiomyopathies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6045748/
https://ncbi.nlm.nih.gov/pubmed/30018782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000845
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller